APA (7th ed.) Citation

Zhang, J., Sethuraman, J., Herrman, M., Murthy, P., Kaur, R., Wong, J. T. S., . . . Jakobovits, A. (2025, July). ADI-270: An armored allogeneic gamma delta T cell therapy designed to target CD70-expressing solid and hematologic malignancies. Journal for ImmunoTherapy of Cancer.

Chicago Style (17th ed.) Citation

Zhang, Jie, et al. "ADI-270: An Armored Allogeneic Gamma Delta T Cell Therapy Designed to Target CD70-expressing Solid and Hematologic Malignancies." Journal for ImmunoTherapy of Cancer Jul. 2025.

MLA (9th ed.) Citation

Zhang, Jie, et al. "ADI-270: An Armored Allogeneic Gamma Delta T Cell Therapy Designed to Target CD70-expressing Solid and Hematologic Malignancies." Journal for ImmunoTherapy of Cancer, Jul. 2025.